HER2-positive breast cancer with invasive micropapillary carcinoma component shows immunosuppressive microenvironment and resistance to neoadjuvant therapy

HER2-positive breast cancer with invasive micropapillary carcinoma component shows immunosuppressive microenvironment and resistance to neoadjuvant therapy

BackgroundInvasive micropapillary carcinoma (IMPC) is a rare histopathological subtype of breast cancer (BC) that shows a high incidence of human epidermal growth factor receptor 2 (HER2)-positive expression. However, the therapeutic efficacy of current standard anti-HER2 therapies for this distinct...

Full description

Saved in:
Bibliographic Details
Main Authors: Lulu Zhang, Lijia Zhou, Anli Yang, Shaoquan Zheng, Keming Chen, Yutian Zou, Qingru Zhou, Daining Wang, Fei Xu, Jiajia Huang, Zhongyu Yuan, Shusen Wang, Yanxia Shi, Peng Sun, Xin An
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Immunology
Subjects:
HER-2 positive invasive micropapillary carcinoma
resistance to neoadjuvant therapy
immunosuppressive tumor microenvironment
CTNNB1
β-catenin
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1623675/full
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1623675/full

Similar Items